KRAS (G12D) Cooperates with AML1/ETO to Initiate a Mouse Model Mimicking Human Acute Myeloid Leukemia
Background/Aims: It has been demonstrated that KRAS mutations represent about 90% of cancer-associated mutations, and that KRAS mutations play an essential role in neoplastic transformation. Cancer-associated RAS mutations occur frequently in acute myeloid leukemia (AML), suggesting a functional rol...
Main Authors: | Shanmin Zhao, Yuxia Zhang, Kun Sha, Qiu Tang, Xiaohua Yang, Chenlin Yu, Zhixue Liu, Wei Sun, Liping Cai, Chen Xu, Shufang Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2014-01-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/356651 |
Similar Items
-
Geographic Heterogeneity of the AML1-ETO Fusion Gene in Iranian Patients with Acute Myeloid Leukemia
by: Saeedeh Ghazaey Zidanloo, et al.
Published: (2014-10-01) -
Minimal residual disease monitoring via AML1-ETO breakpoint tracing in childhood acute myeloid leukemia
by: Xiaoyan Chen, et al.
Published: (2021-08-01) -
Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML
by: Mu G, et al.
Published: (2020-02-01) -
Gen de fusión AML1-ETO: particularidades en la leucemia mieloide aguda
by: Heidys Garrote Santana, et al. -
A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients
by: Min Yang, et al.
Published: (2022-01-01)